Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents with chronic gastrointestinal symptoms including [bloating/flatulence/diarrhea/abdominal discomfort]. Stool microscopy/PCR confirmed Blastocystis hominis (ST3). Symptoms are intermittent, and patient denies recent travel to endemic areas or immunocompromise. Clinical significance of ST3 is currently being evaluated in the context of patient's overall symptom burden.
Clinical Examination Findings
Abdominal examination reveals [soft/distended/tender] abdomen. Bowel sounds are [normal/hyperactive]. No signs of peritoneal irritation or organomegaly. Patient is hemodynamically stable, afebrile, and shows no signs of dehydration. Mucous membranes are moist.
Treatment Protocol
Given the controversial pathogenicity of Blastocystis hominis (ST3), treatment is reserved for symptomatic patients after excluding other etiologies. Plan: 1. Trial of Metronidazole [500mg BID for 5-7 days] or Paromomycin. 2. Probiotic supplementation. 3. Re-evaluation of symptoms post-treatment. 4. If symptoms persist, investigate for alternative diagnoses (e.g., IBS, SIBO).